Abstract |
It has been generally accepted that genotoxic carcinogens have no threshold in exerting their potential for cancer induction. However, the non-threshold theory can be challenged for cancer risk assessment in humans. Here we examined low dose carcinogenicity of a food-derived, genotoxic hepatocarcinogen, 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx), using an in vivo medium-term bioassay to detect initiating activity for rat hepatocarcinogenesis. With MeIQx initiation at various doses followed by administration of phenobarbital, a well known hepatopromoter, no induction of glutathione S-transferase placental form-positive foci, assessed as preneoplastic lesions, was noted at doses of 0.001-1 ppm. The results imply a no-observed effect level for hepatocarcinogenicity with this genotoxic agent.
|
Authors | Shoji Fukushima, Hideki Wanibuchi, Keiichirou Morimura, Min Wei, Dai Nakae, Yoichi Konishi, Hiroyuki Tsuda, Nobuo Takasuka, Katsumi Imaida, Tomoyuki Shirai, Masae Tatematsu, Tetsuya Tsukamoto, Masao Hirose, Fumio Furukawa |
Journal | Cancer letters
(Cancer Lett)
Vol. 191
Issue 1
Pg. 35-40
(Feb 28 2003)
ISSN: 0304-3835 [Print] Ireland |
PMID | 12609707
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- Carcinogens
- Quinoxalines
- 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline
- Glutathione Transferase
- Phenobarbital
|
Topics |
- Animals
- Biomarkers
(analysis)
- Carcinogens
(administration & dosage, toxicity)
- Cocarcinogenesis
- Dose-Response Relationship, Drug
- Drug Synergism
- Glutathione Transferase
(analysis)
- Liver
(drug effects, enzymology)
- Liver Neoplasms, Experimental
(chemically induced)
- Male
- Phenobarbital
(toxicity)
- Precancerous Conditions
(chemically induced, enzymology)
- Quinoxalines
(administration & dosage, toxicity)
- Rats
- Rats, Inbred F344
|